Met909 Plays a Key Role in the Activation of the Progesterone Receptor and Also in the High Potency of 13-Ethyl Progestins
- 16 March 2009
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 75 (6), 1317-1324
- https://doi.org/10.1124/mol.108.054312
Abstract
Many progestins have been developed for use in contraception, menopausal hormone therapy, and treatment of gynecological diseases. They are derived from either progesterone or testosterone, and they act by binding to the progesterone receptor (PR), a hormone-inducible transcription factor belonging to the nuclear receptor superfamily. Unlike mineralocorticoid, glucocorticoid, and androgen receptors, the steroid-receptor contacts that trigger the switch of the ligand-binding domain from an inactive to an active conformation have not yet been identified for the PR. With this aim, we solved the crystal structure of the ligand-binding domain of the human PR complexed with levonorgestrel, a potent testosterone-derived progestin characterized by a 13-ethyl substituent. Via mutagenesis analysis and functional studies, we identified Met909 of the helix 12 as the key residue for PR activation by both testosterone- and progesterone-derived progestins with a 13-methyl or a 13-ethyl substituent. We also showed that Asn719 contributes to PR activation by testosterone-derived progestins only, and that Met759 and Met909 are responsible for the high potency of 19-norprogestins and of 13-ethyl progestins, respectively. Our findings provide a structural guideline for the rational synthesis of potent PR agonist and antagonist ligands that could have therapeutic uses in women's health.Keywords
This publication has 30 references indexed in Scilit:
- International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen ReceptorsPharmacological Reviews, 2006
- Comparison of crystal structures of human androgen receptor ligand‐binding domain complexed with various agonists reveals molecular determinants responsible for binding affinityProtein Science, 2006
- Mechanism of the nuclear receptor molecular switchTrends in Biochemical Sciences, 2004
- Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen ReceptorPublished by Elsevier BV ,2000
- Crucial Role of the H11-H12 Loop in Stabilizing the Active Conformation of the Human Mineralocorticoid ReceptorMolecular Endocrinology, 2000
- Functional Probing of the Human Glucocorticoid Receptor Steroid-interacting Surface by Site-directed MutagenesisPublished by Elsevier BV ,2000
- Synthesis and biological activity of a new progestogen, 16-methylene-17α-hydroxy-18-methyl-19-norpregn-4-ene-3,20-dione acetateSteroids, 2000
- The mineralocorticoid activity of progesterone derivatives depends on the nature of the C18 substituentEndocrinology, 1995
- Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constantsJournal of Applied Crystallography, 1993
- PROCHECK: a program to check the stereochemical quality of protein structuresJournal of Applied Crystallography, 1993